These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 1378313)

  • 41. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity.
    Nugent MA; Edelman ER
    Biochemistry; 1992 Sep; 31(37):8876-83. PubMed ID: 1390674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
    Fannon M; Forsten KE; Nugent MA
    Biochemistry; 2000 Feb; 39(6):1434-45. PubMed ID: 10684625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms.
    Roghani M; Moscatelli D
    J Biol Chem; 1992 Nov; 267(31):22156-62. PubMed ID: 1429568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury.
    Buczek-Thomas JA; Nugent MA
    J Biol Chem; 1999 Aug; 274(35):25167-72. PubMed ID: 10455199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factor (FGF)-2 mediates cell attachment through interactions with two FGF receptor-1 isoforms and extracellular matrix or cell-associated heparan sulfate proteoglycans.
    Richard C; Roghani M; Moscatelli D
    Biochem Biophys Res Commun; 2000 Sep; 276(2):399-405. PubMed ID: 11027487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
    Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
    Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations.
    Reiland J; Rapraeger AC
    J Cell Sci; 1993 Aug; 105 ( Pt 4)():1085-93. PubMed ID: 8227197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells.
    Emoto N; Isozaki O; Ohmura E; Shizume K; Tsushima T; Demura H
    Thyroid; 1995 Dec; 5(6):455-60. PubMed ID: 8808095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.
    Miao HQ; Ishai-Michaeli R; Atzmon R; Peretz T; Vlodavsky I
    J Biol Chem; 1996 Mar; 271(9):4879-86. PubMed ID: 8617759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
    Yayon A; Klagsbrun M; Esko JD; Leder P; Ornitz DM
    Cell; 1991 Feb; 64(4):841-8. PubMed ID: 1847668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
    Saksela O; Rifkin DB
    J Cell Biol; 1990 Mar; 110(3):767-75. PubMed ID: 2137829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.
    Chang HC; Samaniego F; Nair BC; Buonaguro L; Ensoli B
    AIDS; 1997 Oct; 11(12):1421-31. PubMed ID: 9342064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.
    Rapraeger AC; Krufka A; Olwin BB
    Science; 1991 Jun; 252(5013):1705-8. PubMed ID: 1646484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
    Coltrini D; Rusnati M; Zoppetti G; Oreste P; Grazioli G; Naggi A; Presta M
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.
    Rusnati M; Presta M
    Int J Clin Lab Res; 1996; 26(1):15-23. PubMed ID: 8739851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.
    Watson JB; Getzler SB; Mosher DF
    J Clin Invest; 1994 Jul; 94(1):261-8. PubMed ID: 8040268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis.
    Fujiwara Y; Kaji T
    Toxicology; 1999 Apr; 133(2-3):147-57. PubMed ID: 10378481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
    Nugent MA; Karnovsky MJ; Edelman ER
    Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E; Quarck R; Fontenay-Roupie M; Lévy-Toledano S; Tobelem G; Bryckaert M
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.
    Etscheid M; Beer N; Kress JA; Seitz R; Dodt J
    Eur J Cell Biol; 2004 Jan; 82(12):597-604. PubMed ID: 15035435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.